
|Articles|August 20, 2012
Considerations for the Development and Manufacturing of Biosimilars [Presentation]
Advertisement
This content is provided by Amgen.
Divided into 3 sections, this presentation provides insight into the complexities of developing and manufacturing biologics and discusses considerations for the development of biosimilars.
Please click the image below to view the presentation.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol
2
Cardiology Prices Vary Widely by Insurer and State
3
Medicaid MFN Pricing Could Save $8.6 Billion
4
CRC Treatment Delays Linked to Higher Metastasis Risk, Supporting Pathway-Specific Benchmarks
5




